Purpose To demonstrate that patients with hepatocellular carcinoma (HCC) and elevated
baseline neutrophil/lymphocyte ratio (NLR) have a significantly greater risk of progressive …

Purpose To evaluate whether the neutrophil-to-lymphocyte ratio (NLR) predicts survival in
patients with unresectable hepatocellular carcinoma (HCC) before and after transarterial …

Background Prospectively predicting response to intra-arterial therapy for hepatocellular
carcinoma (HCC) is challenging. Neutrophil/lymphocyte ratio (NLR) is a serum biomarker …

Purpose To assess the prognostic value of neutrophil-to-lymphocyte ratio (NLR) in patients
with unresectable intermediate-or advanced-stage hepatocellular carcinoma (HCC) treated …

Purpose To examine the effect of dynamic changes in neutrophil-to-lymphocyte ratio (NLR)
on tumor response and overall survival (OS) in patients with hepatocellular carcinoma …

Background Neutrophil-to-lymphocyte ratio (NLR) is considered as a prognostic predictor of
hepatocellular carcinoma (HCC). However, its prognostic ability is still controversial. This …

Simple Summary Baseline neutrophil-to-lymphocyte ratio≥ 3 was a robust independent
predictor of overall survival after chemoembolization for intermediate-stage hepatocellular …

Purpose To evaluate the ability of neutrophil-to-lymphocyte ratio (NLR), platelet-to-
lymphocyte ratio (PLR), aspartate aminotransferase-to-lymphocyte ratio (ALRI) and systemic …

Purpose To evaluate whether neutrophil-to-lymphocyte ratio (NLR) and platelet-to-
lymphocyte ratio (PLR) predict survival and metastasis in patients after transarterial …

Background Accumulating evidence indicates that systemic inflammation response is
associated with the prognosis of various cancers. The aim of this study was to investigate the …